Abstract
At the current time, cancer claims the lives of approximately seven million people worldwide on an annual basis. In the United States alone, there are approximately one million new cases diagnosed each year, and approximately one-half million succumb to the disease. However, various cancer causes and methods of prevention are now obvious, and this knowledge should be brought to bear by members of an enlightened society. As an example, over 100,000 individuals in the United States die per year due to the manifestations of lung cancer, and a large percentage of these deaths could undoubtedly be negated by abolishing the smoking of cigarettes. In fact, the National Cancer Institute has devised a campaign in which the goal is to reduce the 1985 cancer mortality rate by 50% by the year 2000.1 The approach to achieving this goal is understandably comprehensive. In addition to primary prevention strategies (e. g., cessation of cigarette smoking, reduction of exposure to chemical carcinogens), elements such as early diagnosis, dietary modification, and cancer training programs will need to be emphasized.2
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Greenwald, P., Sondik, E., Lynch, B.S. 1986. Diet and chemoprevention in Nci’s research strategy to achieve national cancer control objectives. Annu. Rev. Public Health 7: 267–291.
Greenwald, P., Cullen, J.W., McKenna, J.W. 1987. Cancer prevention and control from research through applications. J. Natl. Cancer Inst. 79: 389–400.
Bertram, J.S., Kolonel, L.N., Meyskens, Jr., F.L. 1987. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47: 3012–3031.
Malone, W.F., Kelloff, G.J., Boone, C., Nixon, D.W. 1989. Chemoprevention and modern cancer prevention. Prevent. Med. 18: 553–561.
Greenwald, P., Nixon, D.W., Malone, W.F., Kelloff, G.J., Stern, H.R., Lit-Kin, K.M. 1990. Concepts in cancer chemoprevention research. Cancer 65: 1483–1490.
Costa, A., Santoro, G., Assimakopoulos, G. 1990. Cancer chemoprevention: A review of ongoing clinical trials. Acta Oncol. 29: 657–663.
Bjelke, E. 1975. Dietary vitamin A and human lung cancer. Int. J. Cancer 15: 561–565.
Shekelle, R.B., Liu, S., Raynor, Jr., W.J., Lepper, M., Makza, C., Rossof, A.H., Paul, O., Shryock, A.M., Stamiler, J. 1981. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 2: 1185–1189.
Hirayama, T. 1979. Diet and cancer. Nutr. Cancer 1: 67–81.
Block, G. 1992. Vitamin C status and cancer. Epidemiologic evidence of reduced risk. Ann. N.Y. Acad. Sci. 669: 281–292.
Hocman, G. 1992. Chemoprevention of cancer: Protease inhibitors. Int. J. Biochem. 24: 1365–1375.
Troll, W. 1989. Protease inhibitors interfere with the necessary factors of carcinogenesis. Environ. Health Perspect. 81: 59–62.
Knekt, P. 1992. Vitamin E and cancer: Epidemiology. Ann. N.Y. Acad. Sci. 669: 269–279.
Butterworth, Jr., C.E. 1992. Effect of folate on cervical cancer. Ann. N.Y. Acad. Sci. 669: 293–299.
Cordell, G.A., Pezzuto, J.M., Hamburger, M.O., Gunawardana, Y.A.G.R, Shieh, H.-L., McPherson, D.D. 1989. Recent studies on anticancer agents. In: Progress in Chemistry of Medicinal Plants in Asia. Proceedings of the Sixth Asian Symposium on Medicinal Plants and Spices. Bandung, Indonesia. pp 243-254.
Cordell, G.A., Farnsworth, N.R., Beecher, C.W.W., Soejarto, D.D., King-Horn, A.D., Pezzuto, J.M., Wall, M.E., Wani, M.C., Cobb, R.R., Harris, T.J.R., O’Neill, M.J., Tait, R.M. 1994. Novel strategies for the discovery of plant-derived anticancer agents. In: Second Symposium on Anticancer Drug Discovery and Development, Traverse City, Michigan, June 27–29, 1991. Kluwer Adademic Publishers, Boston. pp. 63–83.
Tan, G.T., Pezzuto, J.M., Kinghorn, A.D. 1992. Screening of natural products as HIV-1 and HIV-2 reverse transcriptase (RT) inhibitors. In: Natural Products as Antiviral Agents. (C.K. Chu, H. Cutler, eds.). Plenum Press, N.Y. pp 195–222.
Cordell, G.A., Kinghorn, A.D., Pezzuto, J.M. 1993. Separation, structure elucidation and bioassay of cytotoxic natural products. In: Bioactive Natural Products: Detection, Isolation and Structural Identification. (S.M. Colegate, R.J. Molyneux, eds.). CRC Press, Boca Raton. pp 195–219.
Shamon, L., Pezzuto, J.M. 1994. Plant antimutagens: A review and strategy for the identification of therapeutically useful agents. In: Economic and Medicinal Plant Research. Vol. 6. (N.R. Farnsworth, H. Wagner, eds.). Academic Press, London. pp 235–297.
Angerhofer, C.K., König, G.M., Wright, A.D., Sticher, O., Milhous, W.K., Cordell, G.A., Farnsworth, N.R., Pezzuto, J.M. 1993. Selective screening of natural products: A resource for the discovery of novel antimalarial compounds. In: New Trends in Natural Products Chemistry. (Atta-ur-Rahman, ed.). pp 431–443.
Cordell, G.A., Farnsworth, N.R., Beecher, C.W.W., Soejarto, D.D., Kinghorn, A.D., Pezzuto, J.M., Wall, M.E., Wani, M.C., Brown, D.M., O’Neill, M.J., Lewis, J.A., Tait, R.M., Harris, T.J.R. 1993. Novel strategies for the discovery of plant-derived anticancer agents. In: Human Medicinal Agents from Plants (ACS Symposium Series No. 534). (A.D. Kinghorn, M.F. Balandrin, eds.) A.CS. Wash. D.C. pp 191–204.
Pezzuto, J.M. 1993. Cancer chemopreventive agents: From plant materials to clinical intervention trials. In: Human Medicinal Agents from Plants (Acs Symposium Series No. 534). (A.D. Kinghorn, M.F. Balandrin, eds.). A.C.S. Wash. D.C. pp 205–217.
Suffness, S.M., Pezzuto, J.M. 1991. Assays for cytotoxicity and antitumor activity. Chapter 4. In: Methods of Plant Biochemistry, Vol. 9. (K. Hostettmann ed.). Academic Press, London. pp 71–133.
Kinghorn, A.D., Balandrin, M.F. (eds.). 1993. Human Medicinal Agents from Plants (ACS Symposium Series No. 534). A.C.S. Wash. D.C pp 356.
Cordell, G.A., Beecher, C.W.W., Pezzuto, J.M. 1991. Can ethnopharmacology contribute to the development of new anticancer drugs? J. Ethnopharmacol. 32: 117–133.
Angerhofer, C.K., Pezzuto, J.M. 1993. Applications of biotechnology for drug discovery and evaluation. In: Biotechnology and Pharmacy. (J.M. Pezzuto, M.E. Johnson, H.R. Manasse, Jr., eds.). Chapman and Hall, N.Y. pp 312–365.
Cassady, J.M., Baird, W.M., Chang, C-J. 1990. Natural products as a source of potential cancer chemotherapeutic and chemopreventive Agents. J. Nat. Prod. 53: 23–41.
Muto, Y., Ninomiya, M., Fujiki, H. 1990. Present status of research on cancer chemoprevention in Japan. Jpn. J. Clin. Oncol. 20: 219–224.
Bertram, J.S., Hossain, M.Z., Pung, A, Rundhaug, J.E. 1989. Development of in vitro systems for chemoprevention research. Prev. Med. 18: 562–575.
Beecher, C.W.W., Farnsworth, N.R., Fong, H.H.S., Kinghorn, A.D., Mehta, R.G., Moon, R.C., Moriarty, R.M., Pezzuto, J.M., Soejarto, D.D., Wall, M.E., Wani, M. 1993. Identification and Characterization of Natural Inhibitors of Carcinogene-sis. Proc. Am. Assoc. Cancer Res. 34:559.
Shamon, L.A., Chen, C., Mehta, R.G., Steele, V., Moon, R.C., Pezzuto, J.M. A correlative approach for the discovery of antimutagens that demonstrate cancer chemopreventive activity. Anticancer Res. 14: in press.
Ip, C., Ganther, H. E. 1991. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12: 365–367.
Zhang, Y., Talalay, P., Cho, C.-G., Posner, G.H. 1992. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA 89: 2399–2403.
Prochaska, H.J., Santamaria, A.B., Talalay, P. 1992. Rapid detection of in-ducers of enzymes that protect against carcinogens. Proc. Natl. Acad. Sci. Usa 89: 2394–2398.
De Long, M., Santamaria, A.B., Talalay, P. 1987. Role of cytochrome Pl-450 in the induction of NAD(P)H:quinone reductase in a murine hepatoma cell line and its mutants. Carcinogenesis 8: 1549–1553.
Miller, A.G., Israel, D., Whitlock, Jr., J.P. 1983. Biochemical and genetic analysis of variant mouse hepatoma cells defective in induction of benzo(a)pyrene-metabolizing enzyme activity. J. Biol. Chem. 258: 3523–3527.
Takai, Y., Kikkawa, U., Kaibuchi, K., Nishizuka, Y. 1984. Membrane phospholipid metabolism and signal transduction for protein phosphorylation. Adv. Cyclic Nucleotide Prot. Phosphoryl. Res. 18: 119–158.
Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698.
Castagna, M., Takai, Y, Kaibuchi, K., Sano, K., Kikkawa, U., Nishizuka, Y. 1982. Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257: 7847–7851.
Bell, R.M. 1986. Protein kinase C activation by diacylglycerol second messengers. Cell 45: 631–632.
Verma, A.K. 1988. The protein kinase C activator L-α-dioctanoylglycerol: A potent stage II mouse skin tumor promoter. Cancer Res. 48: 1736–1739.
Cerutti, P.A. 1988. Oxidant tumor promoter. In: UCLA Symposia on Molecular and Cellular Biology New Series, Vol. 58, Growth Factors, Tumor Promoters, and Cancer Genes. (N.H. Colburn, H.L. Moses, E.J. Stanbridge, eds.). Alan R. Liss, Inc., N.Y. pp 239–247.
Lupulescu, A. 1978. Enhancement of carcinogenesis by Prostaglandins. Nature 272: 634–636.
Reddy, B.S. 1992. Inhibitors of the arachidonic acid cascade and their chemoprevention of colon carcinogenesis. In: Cancer Chemoprevention. (L. Wattenberg, M. Lipkin, C.W. Boone, G.L. Kelloff, eds.). CRC Press, Boca Raton. pp 153–164.
Verma, A.K., Ashendel, C.L., Boutwell, R.K. 1980. Inhibition by Prostaglandin synthesis inhibitors of the induction of epidermal Ornithine decarboxylase activity, the accumulation of Prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 40: 308–315.
Collins, S.J. 1987. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233–1244.
Eismam, J.A., Koga, M., Sutherland, R.L., Barkla, D.H., Tutton, P.J.M. 1989. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. P.S.E.B.M. 191: 221–226.
Colston, K.W., Berger, U., Coombes, R.C. 1989. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet, January 28, 1989, pp 188-191.
Colston, K., Wilkinson, J.R., Coombes, R.C. 1986. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor. Endocrinol. 119: 397–403.
Han, X.L., Liehr, J.G. 1992. Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res. 52: 1360–1363.
Smigel, K. 1992. Breast cancer prevention trial takes off. J. Natl. Cancer Inst. 84: 669–670.
Sasson, S., Notides, A.C. 1988. Mechanism of the estrogen receptor interaction with 4-hydroxytamoxifen. Mol. Endocrinol. 2: 307–312.
Geier, A., Beery, R., Haimsohn, M., Lunenfeld, B. 1987. Analysis of the 4-hydroxytamoxifen (4-Ohtam) bound nuclear estrogen receptor from MCF-7 cells by limited proteolysis. J. Steroid Biochem. 28: 471–478.
Metzger. D., Losson, R., Bornert, J.M., Lemoine, Y., Chambon, P. 1992. Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast. Nucleic Acids Res. 20: 2813–2817.
Fawell, S.E., White, R., Hoare, S., Sydenham, M., Page, M., Parker, M.G. 1990. Inhibition of estrogen receptor-DNA binding by the “pure” antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 87: 6883–6887.
Antoniotti, S., Maggiora, P., Dati, C., Debortoli, M. 1992. Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro. Eur. J. Cancer. 28: 318–321.
Lykkesfeldt, A.E., Sorensen, E.K. 1992. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1. Acta Oncol. 31: 131–138.
Sutherland, R.L., Watts, C.K., Hall, R.E., Ruenitz, P.C. 1987. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells. J. Steroid Biochem. 27: 891–897.
Littlefield, B.A., Gurpide, R., Markiewicz, L., Mckinley, B., Hochberg, R.B. 1990. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline Phosphatase in Ishikawa cells: Estrogenic action of A 5 adrenal steroids. Endocrinol. 127: 2757–2762.
Albert, J.L., Sundstrom, S.A., Lyttle, C.R. 1990. Estrogen regulation of placental alkaline Phosphatase gene expression in a human endometrial adenocarcinoma cell line. Cancer Res. 50: 3306–3310.
Holinka, C.F., Hata, H., Kuramoto, H., Gurpide, E. 1986. Effects of steroid hormones and antisteroids on alkaline Phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res. 46: 2771–2774.
Anon. 1982. Aromatase: New Perspectives for Breast Cancer. Cancer Res. (Suppl.) 42:3261s–3469s.
Coombes, R.C., Evans, T.R.J. 1991. Aromatase Inhibitors 2. In: The Medical Management of Breast Cancer. (T. Powles, I.E. Smith, eds.). Martin Dunitz, London, pp 81–93.
Wouters, W., De Coster, R., Krekels, M., Van Dun, J., Beererns, D., Haelterman, C., Raeymaekers, A., Freyne, E., Van Gelder, J., Venet, M., Janssen, Raj. 1989. R76713, Anew specific non-steroidal aromatase inhibitor. J. Steroid Biochem. 32: 781–788.
De Coster, R., Wouters, W., Bowden, C.R., Vanden Bossche, H., Bruyn-Seels, J., Tuman, R.W., Vanginckel, R., Snoeck, E., Van Peer, A., Janssen, P.A.J. 1990. New non-steroidal aromatase inhibitors: Focus on R76713. J. Steroid Biochem. Mol. Biol. 37: 335–341.
Mehta, R.G., Constantinou, A., Moriarty, R., Pezzuto, J.M., Moon, R.C. 1993. Brassinin: A novel chemopreventive agent. Proc. Am. Assoc. Cancer Res. 34: 127.
Mehta, R.G., Moriarty, R.M., Liu, J., Constantinou, A., Thomas, C., Hawthorne, M., You, M., Gerhäuser, C., Pezzuto, J.M., Moon, R.C. Synthesis and cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis, in press.
Mehta, R.G., Liu, J., Constantinou, A., Hawthorne, M., Pezzuto, J.M., Moon, R.C., Moriarty, R.M. Structure-activity relationships of brassinin in preventing the development of carcinogen-induced mammary lesions in mammary gland organ culture. Anticancer Res. 14: 1209–1213.
You, M., Gerhäuser, C., Liu, J., Moriarty, R.M., Mehta, R.G., Moon, R.C., Pezzuto, J.M. 1994. Induction of quinone reductase activity mediated by brassinin and its derivatives. Proc. Am. Assoc. Cancer Res. 35:627.
Ishii, R., Yoshikawa, K., Minakata, H., Komura, H., Kada, T. 1984. Specificity of bio-antimutagens in plant kingdom. Agr. Biol. Chem. 48: 2587–2591.
Beecher, C.W.W., Pezzuto, J.M., Farnsworth, N.R. 1993. Meta-analysis of published literature as a means of chemopreventive drug discovery. Proc. Am. Assoc. Cancer Res. 34:127.
Kinghorn, A.D., Mehta, R.G., Moon, R.C., Pezzuto, J.M. 1993. Bioassay-directed isolation of natural inhibitors of carcinogenesis. Proc. Am. Assoc. Cancer Res. 34:558.
Herbert, J.M., Augereau, J.M., Gleye, J., Maffrand, J.P. 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993–999.
Luyengi, L., Lee, I.-S., Mar, W., Fong, H.H.S., Pezzuto, J.M., Kinghorn, A.D. Rotenoids and chalcones from Mundulea sericea that inhibit phorbol ester-induced Ornithine decarboxylase activity. Phytochemistry 36: 1523–1526.
Pezzuto, J.M., Mar, W., Luyengi, L., Kinghorn, A.D., Fong, H.H.S., Halline, A.G., Mehta, R.G., Moon, R.C. 1994. Rotenoid-mediated inhibition of Ornithine decarboxylase activity as a mechanism of chemopreventive activity. Proc. Am. Assoc. Cancer Res. 35:627.
Boone, C.W., Kelloff, G.J., Malone, W.E. 1990. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human intervention trials: A review. Cancer Res. 50: 2–9.
Sporn, M.B., Squire, R.A., Brown, C.C., Smith, J.M., Wenk, M.L., Springer, S. 1977. 13-cis-Retinoic acid: Inhibition of bladder carcinogenesis in rats. Science 195: 487–489.
Moon, R.C., Grubbs, C.J., Sporn, M.B., Goodman, D.G. 1977. Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea. Nature 267: 620–621.
Sporn, M.B., Clamon, G.H., Dunlop, N.M., Newton, D.L., Smith, J.M., Saf-Fiotti, U. 1975. Activity of vitamin A analogs in cell cultures of mouse epidermis and organ culture of hamster trachea. Nature 253: 47–50.
Moon, R.C., Thompson, H.J., Becci, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen, L.T., Brown, C.C., Sporn, M.B. 1979. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in rat. Cancer Res. 39: 1339–1346.
McCormick, D.L., Mehta, R.G., Thompson, C.A., Dinger, N., Caldwell, J.L., Moon, R.C. 1982. Enhanced inhibition of mammary carcinogenesis by combination of N-(4-hydroxyphenyl)retinamide and ovariectomy. Cancer Res. 42: 508–512.
Moon, R.C., Mehta, R.G., Rao, K.V.N. 1993. Retinoids and cancer in experimental animals. In: The Retinoids: Biology, Chemistry and Medicine, Second edition. (M.B. Sporn, A.B. Roberts, D.S. Goodman, eds.). pp 573-592.
Malone, W. F. 1991. Studies evaluating antioxidants and β-carotene as chemopreventives. Am. J. Clin. Nutr. 53:305S–313S.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pezzuto, J.M. (1995). Natural Product Cancer Chemopreventive Agents. In: Arnason, J.T., Mata, R., Romeo, J.T. (eds) Phytochemistry of Medicinal Plants. Recent Advances in Phytochemistry, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1778-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1778-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1780-5
Online ISBN: 978-1-4899-1778-2
eBook Packages: Springer Book Archive